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Background 
Direct-acting antivirals (DAAs) for HCV treatment achieve high success rates, but 
are more likely to select for viral drug-resistant mutants. DAA combination 
therapies targeting different viral proteins are used to tackle this problem. In 
order to detect resistance mutations simultaneously in all viral target genes 
under selective pressure, a full-genome assay was developed. Both population 
and next-generation sequencing were performed, but the analysis of NGS data 
from diverse viral populations remains a non-trivial exercise. In order to 
accommodate the specific characteristics of short read fragment data, the 
impact of tailored analysis methodologies and of reference sequence 
divergence on the recovery of minority variants, was studied. 
Material and methods 
Four samples from treatment-naïve HCV1b infected patients were amplified by 
nested PCR and sequenced with Illumina’s Genome Analyzer IIx. The 
performance of four software packages for aligning reads against three 
reference sequences was tested:  
• a published HCV1b reference sequence (AB049087) 
• a consensus of the respective sample obtained by Sanger sequencing 
• an in silico reconstructed data-specific reference sequence (VICUNA ) 
Concordance between the viral population after Sanger sequencing and after 
read mapping with Segminator II, was compared. An approximate maximum-
likelihood tree was constructed to evaluate the covered variability spectrum. 
Results 
Performance of packages to align reads to a reference sequence 
Conclusions 
Only a few software packages can accommodate the diversity present in 
heterogeneous viral populations. Using a distantly related reference sequence 
leads to substantial data loss, even with the best among the packages, 
Segminator II. Although the consensus sequence is largely independent of the 
used reference sequence, when discordances (mostly differences in mixtures) 
do occur, they are enriched in highly divergent regions. So the use of sample-
specific reference sequences for read mapping, is recommended. 
For all packages, the number of mapped reads was consistently higher when a 
sample-specific sequence was used instead of the HCV1b AB049087 reference. 
Segminator II was the best software package in recovering number of reads: 
80,6% (± 3.0) against the sample-specific Sanger sequence, 77.3% (± 2.4) 
against the AB049807 reference and 82.1% (± 4.0) against an in silico data-
specific reference. 
Spectrum of variability covered by the assay 
Reference sequence 
Major + minor discordance (%, 
stdev) 
Major discordance (%, 
stdev) 
HCV1bAB049087 (Genbank) 1,72 (+/- 0,791) 0,30 (+/- 0,092) 
Sanger sequence (sample-
specific) 1,70 (+/- 0,700) 0,026 (+/- 0,014) 
Reconstructed in silico 
reference (data-specific) 1,47 (+/- 0,790) 0,05 (+/- 0,024) 
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Impact of the reference sequence divergence 
41 
29,1 29,3 
73,4 
77,3 77,6 
57,2 
71,4 
80,6 82,1 
0
10
20
30
40
50
60
70
80
90
100
MAQ Bowtie BWA Segminator
II
Re
ad
 c
ov
er
ag
e 
(%
) 
HCV1b AB049087
HCV1b AB049087 with
cycling/remapping
Sanger consensus
VICUNA
The wide dispersion of the HCV1b clade over the deepest branches illustrates 
that this assay captures most of the  variability. 
26 
Figure 1. Mapped reads. Software packages (MAQ, Bowtie, BWA and Segminator II) were used to 
align reads to reference sequences: HCV1b AB049087 (in blue), Sanger consensus (in green) and 
in silico data-specific reference (only Segminator, in red). For MAQ the AB049087 reference was 
used to build a contig which served as reference in the next rounds of mapping (cycling, in dark 
blue) and in case of Segminator II, the template was automatically replaced with the obtained 
consensus during mapping (remapping).  
Table 1. Discordances between Sanger and NGS sequencing. Comparison between the NGS 
consensus sequences obtained by Segminator II (remapping), using all three reference sequences, 
and the sample-specific sequence obtained with Sanger sequencing. Minor discordances are 
predominantly attributable to ambiguity characters in the NGS consensus. Major discordances are 
differences in nucleotides or are due to indels  of one nucleotide.  
Figure 2. Maximum-likelihood tree with FastTree, 1000 bootstraps. Ten samples sequenced by 
Sanger sequencing (blue) and four Illumina sequences (orange), together with a reference alignment 
of LANL including all HCV genotypes. The respective  genotype clades are indicated.   
